Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

Latest Kearns & Associates LLC Stock Portfolio

Kearns & Associates LLC Performance:
2026 Q1: -3.25%YTD: -3.25%2025: 17.64%
Performance for 2026 Q1 is -3.25%, and YTD is -3.25%, and 2025 is 17.64%.

About Kearns & Associates LLC and 13F Hedge Fund Stock Holdings

On 2026-04-20, the fund reported it's updated stock portfolio. In the 13F Holdings report, Kearns & Associates LLC reported an equity portfolio of $185.9 Millions as of 31 Mar, 2026.

The top stock holdings of Kearns & Associates LLC are VB, VB, VEA. The fund has invested 30% of it's portfolio in VANGUARD INDEX FDS and 29.2% of portfolio in VANGUARD INDEX FDS.

The fund managers got completely rid off HERBALIFE LTD (HLF) stocks. They significantly reduced their stock positions in WELLS FARGO & CO (WFC), MARSH & MCLENNAN COS INC (MMC) and STRYKER CORPORATION (SYK). Kearns & Associates LLC opened new stock positions in BAKER HUGHES COMPANY (BKR). The fund showed a lot of confidence in some stocks as they added substantially to VANGUARD INTL EQUITY INDEX F (VEU), SCHWAB STRATEGIC TR (FNDA) and VANGUARD TAX-MANAGED FDS (VEA).

Kearns & Associates LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Kearns & Associates LLC made a return of -3.25% in the last quarter. In trailing 12 months, it's portfolio return was 18.02%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
baker hughes company228,938
New stocks bought by Kearns & Associates LLC

Additions

Ticker% Inc.
vanguard intl equity index f2.71
schwab strategic tr2.58
vanguard tax-managed fds2.08
schwab strategic tr1.16
fidelity merrimack str tr1.11
vanguard index fds0.17
vanguard index fds0.1
Additions to existing portfolio by Kearns & Associates LLC

Reductions

Ticker% Reduced
marsh & mclennan cos inc-25.00
wells fargo & co-25.00
stryker corporation-20.88
royalty pharma plc-17.67
johnson controls internation-17.22
equinix inc-12.21
occidental pete corp-1.3
vanguard index fds-0.66
Kearns & Associates LLC reduced stake in above stock

Sold off

Ticker$ Sold
herbalife ltd-733,441
Kearns & Associates LLC got rid off the above stocks

Sector Distribution

Kearns & Associates LLC has about 87.9% of it's holdings in Others sector.

Sector%
Others87.9
Technology3.8
Financial Services3.5
Healthcare1.9
Communication Services1.5

Market Cap. Distribution

Kearns & Associates LLC has about 12.1% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED87.9
MEGA-CAP8.3
LARGE-CAP3.8

Stocks belong to which Index?

About 10.6% of the stocks held by Kearns & Associates LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others89.4
S&P 50010.6
Top 5 Winners (%)%
OXY
occidental pete corp
57.7 %
EQIX
equinix inc
26.2 %
RPRX
royalty pharma plc
22.0 %
GLD
spdr gold tr
8.6 %
JCI
johnson controls internation
8.6 %
Top 5 Winners ($)$
RPRX
royalty pharma plc
0.6 M
VEA
vanguard tax-managed fds
0.5 M
OXY
occidental pete corp
0.3 M
VB
vanguard index fds
0.2 M
EQIX
equinix inc
0.1 M
Top 5 Losers (%)%
COF
capital one finl corp
-24.7 %
QCOM
qualcomm inc
-24.7 %
MSFT
microsoft corp
-23.5 %
AXP
american express co
-18.2 %
TMO
thermo fisher scientific inc
-15.2 %
Top 5 Losers ($)$
VB
vanguard index fds
-2.7 M
VB
vanguard index fds
-2.5 M
MSFT
microsoft corp
-0.5 M
AAPL
apple inc
-0.4 M
SPY
state str spdr s&p 500 etf t
-0.3 M

Kearns & Associates LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Kearns & Associates LLC

Kearns & Associates LLC has 40 stocks in it's portfolio. About 89% of the portfolio is in top 10 stocks. VB proved to be the most loss making stock for the portfolio. RPRX was the most profitable stock for Kearns & Associates LLC last quarter.

Last Reported on: 20 Apr, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions